All changes for the tissue kidney (65)
Identifier
Name
Type
Tissues
Organism
Gene
Data
Actions
DAA267
amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein
Molecular
kidney
Human
APBB1IP
23.0% Increase Gene Expression Level
DAA266
matrix metallopeptidase 7 (matrilysin, uterine)
Molecular
kidney
Human
MMP7
23.0% Increase Gene Expression Level
DAA265
complement component 1, s subcomponent
Molecular
kidney
Human
C1S
24.0% Increase Gene Expression Level
DAA264
paraoxonase 3
Molecular
kidney
Human
PON3
13.0% Decrease Gene Expression Level
DAA263
claudin 8
Molecular
kidney
Human
CLDN8
17.0% Decrease Gene Expression Level
DAA262
kelch-like 3 (Drosophila)
Molecular
kidney
Human
KLHL3
14.0% Decrease Gene Expression Level
DAA261
hypothetical LOC100126583
Molecular
kidney
Human
—
43.0% Increase Gene Expression Level
DAA260
hypothetical protein LOC284214
Molecular
kidney
Human
—
53.0% Increase Gene Expression Level
DAA259
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides
Molecular
kidney
Human
IGJ
60.0% Increase Gene Expression Level
DAA258
EF-hand domain family, member D1
Molecular
kidney
Human
EFHD1
9.0% Decrease Gene Expression Level
DAA257
kininogen 1
Molecular
kidney
Human
KNG1
17.0% Decrease Gene Expression Level
DAA256
defensin, beta 1
Molecular
kidney
Human
DEFB1
8.0% Decrease Gene Expression Level
DAA2026
Mutations in mitochondrial DNA accumulate
Physiological
heart, kidney, skeletal muscle, cerebral cortex, cerebellum
Human
—
—
DAA2020
Reduction in renal function
Physiological
kidney
Human
—
—
DAA1062
Creatinine clearance declines
Physiological
kidney
Human
—
—
Identifier | Name | Type | Tissues | Organism | Gene | Data | Actions |
---|---|---|---|---|---|---|---|
DAA267 | amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein | Molecular | kidney | Human | APBB1IP | 23.0% Increase Gene Expression Level | |
DAA266 | matrix metallopeptidase 7 (matrilysin, uterine) | Molecular | kidney | Human | MMP7 | 23.0% Increase Gene Expression Level | |
DAA265 | complement component 1, s subcomponent | Molecular | kidney | Human | C1S | 24.0% Increase Gene Expression Level | |
DAA264 | paraoxonase 3 | Molecular | kidney | Human | PON3 | 13.0% Decrease Gene Expression Level | |
DAA263 | claudin 8 | Molecular | kidney | Human | CLDN8 | 17.0% Decrease Gene Expression Level | |
DAA262 | kelch-like 3 (Drosophila) | Molecular | kidney | Human | KLHL3 | 14.0% Decrease Gene Expression Level | |
DAA261 | hypothetical LOC100126583 | Molecular | kidney | Human | — | 43.0% Increase Gene Expression Level | |
DAA260 | hypothetical protein LOC284214 | Molecular | kidney | Human | — | 53.0% Increase Gene Expression Level | |
DAA259 | immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides | Molecular | kidney | Human | IGJ | 60.0% Increase Gene Expression Level | |
DAA258 | EF-hand domain family, member D1 | Molecular | kidney | Human | EFHD1 | 9.0% Decrease Gene Expression Level | |
DAA257 | kininogen 1 | Molecular | kidney | Human | KNG1 | 17.0% Decrease Gene Expression Level | |
DAA256 | defensin, beta 1 | Molecular | kidney | Human | DEFB1 | 8.0% Decrease Gene Expression Level | |
DAA2026 | Mutations in mitochondrial DNA accumulate | Physiological | heart, kidney, skeletal muscle, cerebral cortex, cerebellum | Human | — | — | |
DAA2020 | Reduction in renal function | Physiological | kidney | Human | — | — | |
DAA1062 | Creatinine clearance declines | Physiological | kidney | Human | — | — |